Poly (ADP-ribose): A Double-edged Sword Governing Cancer Cell Survival and Death

Overview

Journal World J Clin Oncol

Publisher Baishideng Publishing Group

Specialty Oncology

Date 2024 Jul 29

PMID 39071462

Authors

Keun-Yeong Jeong

Ji-Hyuk Kang

Affiliations

Soon will be listed here.

Abstract

Poly (ADP-ribose) (PAR), a polymer of ADP-ribose, is synthesized by PAR polymerase and is crucial for the survival of cancer cells due to its vital functions in DNA repair and post-translational modifications. Beyond its supportive role, PAR also triggers cancer cell death by excessive accumulation of PAR leading to an energy crisis and parthanatos. This phenomenon underscores the potential of targeting PAR regulation as a novel anticancer strategy, and the rationale would present an engaging topic in the field of anticancer research. Therefore, this editorial provides an overview of the mechanisms determining cancer cell fate, emphasizing the central role of PAR. It further introduces promising methods for modulating PAR concentrations that may pave the way for innovative anticancer therapies.

References

Palazzo L, Mikolcevic P, Mikoc A, Ahel I . ADP-ribosylation signalling and human disease. Open Biol. 2019; 9(4):190041. PMC: 6501648. DOI: 10.1098/rsob.190041. View

Masutani M, Nakagama H, Sugimura T . Poly(ADP-ribose) and carcinogenesis. Genes Chromosomes Cancer. 2003; 38(4):339-48. DOI: 10.1002/gcc.10250. View

Kassab M, Yu L, Yu X . Targeting dePARylation for cancer therapy. Cell Biosci. 2020; 10:7. PMC: 6988220. DOI: 10.1186/s13578-020-0375-y. View

Luo X, Kraus W . On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012; 26(5):417-32. PMC: 3305980. DOI: 10.1101/gad.183509.111. View

Hopp A, Teloni F, Bisceglie L, Gondrand C, Raith F, Nowak K . Mitochondrial NAD Controls Nuclear ARTD1-Induced ADP-Ribosylation. Mol Cell. 2021; 81(2):340-354.e5. PMC: 7837215. DOI: 10.1016/j.molcel.2020.12.034. View

Chen H, Hu Y, Zhuang Z, Wang D, Ye Z, Jing J . Advancements and Obstacles of PARP Inhibitors in Gastric Cancer. Cancers (Basel). 2023; 15(21). PMC: 10647262. DOI: 10.3390/cancers15215114. View

Beneyton A, Nonfoux L, Gagne J, Rodrigue A, Kothari C, Atalay N . The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. NAR Cancer. 2023; 5(3):zcad043. PMC: 10440794. DOI: 10.1093/narcan/zcad043. View

Min A, Im S . PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation. Cancers (Basel). 2020; 12(2). PMC: 7072193. DOI: 10.3390/cancers12020394. View

Rouleau-Turcotte E, Pascal J . ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. J Biol Chem. 2023; 299(12):105397. PMC: 10722394. DOI: 10.1016/j.jbc.2023.105397. View

10.

Andrabi S, Kim N, Yu S, Wang H, Koh D, Sasaki M . Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci U S A. 2006; 103(48):18308-13. PMC: 1838747. DOI: 10.1073/pnas.0606526103. View

11.

Andronikou C, Rottenberg S . Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance. Trends Mol Med. 2021; 27(7):630-642. DOI: 10.1016/j.molmed.2021.04.010. View

12.

Slade D . PARP and PARG inhibitors in cancer treatment. Genes Dev. 2020; 34(5-6):360-394. PMC: 7050487. DOI: 10.1101/gad.334516.119. View

13.

Brustel J, Muramoto T, Fumimoto K, Ellins J, Pears C, Lakin N . Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones. Nat Commun. 2022; 13(1):185. PMC: 8758696. DOI: 10.1038/s41467-021-27867-4. View

14.

Fatokun A, Dawson V, Dawson T . Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br J Pharmacol. 2014; 171(8):2000-16. PMC: 3976618. DOI: 10.1111/bph.12416. View

15.

Rack J, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K . Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal. Nat Commun. 2021; 12(1):4581. PMC: 8319183. DOI: 10.1038/s41467-021-24723-3. View

16.

Fahrer J, Kranaster R, Altmeyer M, Marx A, Burkle A . Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length. Nucleic Acids Res. 2007; 35(21):e143. PMC: 2175335. DOI: 10.1093/nar/gkm944. View

17.

Slade D . Mitotic functions of poly(ADP-ribose) polymerases. Biochem Pharmacol. 2019; 167:33-43. PMC: 7056360. DOI: 10.1016/j.bcp.2019.03.028. View

18.

Ryu K, Kim D, Kraus W . New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases. Chem Rev. 2015; 115(6):2453-81. PMC: 4378458. DOI: 10.1021/cr5004248. View

19.

Verdone L, La Fortezza M, Ciccarone F, Caiafa P, Zampieri M, Caserta M . Poly(ADP-Ribosyl)ation Affects Histone Acetylation and Transcription. PLoS One. 2015; 10(12):e0144287. PMC: 4670112. DOI: 10.1371/journal.pone.0144287. View

20.

Kim M, Zhang T, Kraus W . Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev. 2005; 19(17):1951-67. DOI: 10.1101/gad.1331805. View